[13th November 2025]
We’re delighted to welcome Dr Jan Bornschein as the newest member of our Medical Advisory Panel.
Our Medical Advisory Panel brings together experienced clinicians from across the UK with a shared focus on Pelvic Radiation Disease (PRD). Their expertise helps ensure that the guidance and information we provide is accurate, evidence-based, and aligned with the best clinical practice.
Dr Bornschein completed his medical training in Magdeburg, Germany, with an early focus on gastrointestinal oncology. He managed the Oncology Outpatients Department there, overseeing the prescription and administration of systemic therapy for cancer patients.
In 2013, he moved to the UK to undertake a Post-Doctoral project at the MRC Cancer Unit, University of Cambridge, exploring the characteristics of cancer at the gastro-oesophageal junction. After a brief period at the University Hospital of Regensburg, Germany, he joined Oxford in 2017, where he now holds a joint position in Gastroenterology and Oncology, managing both acute and late effects of cancer treatment.
Dr Bornschein is also a co-author of the 2024 British Society of Gastroenterology practice guidance on the management of acute and chronic gastrointestinal symptoms and complications as a result of treatment for cancer. His ongoing research and clinical focus include understanding the impact of pelvic radiotherapy on gastrointestinal function—an area of particular relevance to PRD.
We’re honoured to have Dr Bornschein’s expertise and perspective on the panel. His combined experience in oncology, gastroenterology, and research into the late effects of cancer treatment will be invaluable in helping us continue to provide high-quality, evidence-based guidance and support for healthcare professionals working with people affected by Pelvic Radiation Disease.
Learn more about our Medical Advisory Panel